Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. FANTIN B; PIERRE J; CASTELAPAPIN N; SAINTJULIEN L; DRUGEON H; FARINOTTI R; CARBON C
   IMPORTANCE OF PENICILLINASE PRODUCTION FOR ACTIVITY OF PENICILLIN ALONE OR IN COMBINATION WITH SULBACTAM IN EXPERIMENTAL ENDOCARDITIS DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
   Antimicrobial agents and chemotherapy
   
   B. Fantin et al., "IMPORTANCE OF PENICILLINASE PRODUCTION FOR ACTIVITY OF PENICILLIN ALONE OR IN COMBINATION WITH SULBACTAM IN EXPERIMENTAL ENDOCARDITIS DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS", Antimicrobial agents and chemotherapy, 40(5), 1996, pp. 1219-1224
2. CHEMLAL K; SAINTJULIEN L; JOLY V; FARINOTTI R; SETA N; YENI P; CARBON C
   COMPARISON OF FLUCONAZOLE AND AMPHOTERICIN-B FOR TREATMENT OF EXPERIMENTAL CANDIDA-ALBICANS ENDOCARDITIS IN RABBITS
   Antimicrobial agents and chemotherapy
   
   K. Chemlal et al., "COMPARISON OF FLUCONAZOLE AND AMPHOTERICIN-B FOR TREATMENT OF EXPERIMENTAL CANDIDA-ALBICANS ENDOCARDITIS IN RABBITS", Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 263-266
3. FANTIN B; LECLERCQ R; MERLE Y; SAINTJULIEN L; VEYRAT C; DUVAL J; CARBON C
   CRITICAL INFLUENCE OF RESISTANCE TO STREPTOGRAMIN B-TYPE ANTIBIOTICS ON ACTIVITY OF RP-59500 (QUINUPRISTIN-DALFOPRISTIN) IN EXPERIMENTAL ENDOCARDITIS DUE TO STAPHYLOCOCCUS-AUREUS
   Antimicrobial agents and chemotherapy
   
   B. Fantin et al., "CRITICAL INFLUENCE OF RESISTANCE TO STREPTOGRAMIN B-TYPE ANTIBIOTICS ON ACTIVITY OF RP-59500 (QUINUPRISTIN-DALFOPRISTIN) IN EXPERIMENTAL ENDOCARDITIS DUE TO STAPHYLOCOCCUS-AUREUS", Antimicrobial agents and chemotherapy, 39(2), 1995, pp. 400-405
4. JOLY V; FARINOTTI R; SAINTJULIEN L; CHERON M; CARBON C; YENI P
   IN-VITRO RENAL TOXICITY AND IN-VIVO THERAPEUTIC EFFICACY IN EXPERIMENTAL MURINE CRYPTOCOCCOSIS OF AMPHOTERICIN-B (FUNGIZONE) ASSOCIATED WITH INTRALIPID
   Antimicrobial agents and chemotherapy
   
   V. Joly et al., "IN-VITRO RENAL TOXICITY AND IN-VIVO THERAPEUTIC EFFICACY IN EXPERIMENTAL MURINE CRYPTOCOCCOSIS OF AMPHOTERICIN-B (FUNGIZONE) ASSOCIATED WITH INTRALIPID", Antimicrobial agents and chemotherapy, 38(2), 1994, pp. 177-183
5. JOLY V; SAINTJULIEN L; CARBON C; YENI P
   IN-VIVO ACTIVITY OF INTERFERON-GAMMA IN COMBINATION WITH AMPHOTERICIN-B IN THE TREATMENT OF EXPERIMENTAL CRYPTOCOCCOSIS
   The Journal of infectious diseases
   
   V. Joly et al., "IN-VIVO ACTIVITY OF INTERFERON-GAMMA IN COMBINATION WITH AMPHOTERICIN-B IN THE TREATMENT OF EXPERIMENTAL CRYPTOCOCCOSIS", The Journal of infectious diseases, 170(5), 1994, pp. 1331-1334